Don’t be afraid of Atyr Pharma Inc (LIFE) Stock despite uncertainty and doubt
Oppenheimer raised the price target for the Atyr Pharma Inc (NASDAQ:LIFE) stock from “an Outperform” to “a Perform”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $19. The stock was initiated by Laidlaw, who […]
Top-line Growth is Likely to Be Driven by Atyr Pharma Inc (LIFE) Stock
Oppenheimer raised the price target for the Atyr Pharma Inc (NASDAQ:LIFE) stock from “an Outperform” to “a Perform”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $19. The stock was initiated by Laidlaw, who […]
Is it possible to sustain this rally? Atyr Pharma Inc (LIFE) Stock
Oppenheimer raised the price target for the Atyr Pharma Inc (NASDAQ:LIFE) stock from “an Outperform” to “a Perform”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $19. The stock was initiated by Laidlaw, who […]
Does Atyr Pharma Inc (LIFE) Stock have a positive outlook following recent trade?
Oppenheimer raised the price target for the Atyr Pharma Inc (NASDAQ:LIFE) stock from “an Outperform” to “a Perform”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $19. The stock was initiated by Laidlaw, who […]
Atyr Pharma Inc (LIFE) Stock is expected to generate profits in the near future
Oppenheimer raised the price target for the Atyr Pharma Inc (NASDAQ:LIFE) stock from “an Outperform” to “a Perform”. The rating was released on July 05, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $19. The stock was initiated by Laidlaw, who […]
